Drugs access: Why the NHS is failing those with uncommon conditions
This contrasts greatly with the Royal National Institute … The health service responded by producing an in-year commissioning policy for among the drugs in question and referred the other two to NICE for evaluation. Sadly, this has introduced further …
See Initial Article